Sandbox/v23: Difference between revisions

Jump to navigation Jump to search
mNo edit summary
mNo edit summary
Line 3: Line 3:


{{Family tree/start}}
{{Family tree/start}}
{{familytree | | | | | | | | | | | | | | | | | | | | | | | | | A01 | | | | | | | | | | | | | | A01=<div style="float: left; text-align: left; height: 50em; width: 15em; padding:1em;"> '''Characterize the symptoms:'''<br>
{{familytree |border=2|boxstyle=background: WhiteSmoke;| | | | | | | | | | | | | | | | | | | | | | | | | A01 | | | | | | | | | | | | | | A01=<div style="float: left; text-align: left; height: 50em; width: 30em; padding: 0.5em;">'''Characterize the symptoms:'''<br>
 
----
----
❑ [[Abdominal pain]] <br>
❑ [[Abdominal pain]] <br>
❑ [[Diarrhea|Chronic diarrhea or nocturnal diarrhea]] (onset, duration, pattern, bloody, mucous or watery) <br>
❑ [[Diarrhea|Chronic diarrhea or nocturnal diarrhea]] <br>
 
▸ Onset, duration, pattern, character (bloody, mucous, or watery) <br>
❑ [[Nausea]] <br>
❑ [[Nausea]] <br>
❑ [[Vomiting]] <br>
❑ [[Vomiting]] <br>
Line 13: Line 16:
❑ [[Loss of appetite]] <br>
❑ [[Loss of appetite]] <br>
❑ [[Loss of weight]] <br>
❑ [[Loss of weight]] <br>
Mental status change <br>
[[Altered mental status]] <br>
Rectal  bleeding <br>
[[Hematochezia]] <br>
Painful defecation <br>
[[Tenesmus]] <br>
----
----
'''Extraintestinal symptoms:'''<br>
'''Extraintestinal symptoms:'''<br>
Line 102: Line 105:


{{Family tree/end}}
{{Family tree/end}}
==1==
{{Family tree/start}}
{{familytree | | | | | | | C01 | | | | | | | | | | | | | | | | C02 | | | | | | | | | C03 | | | | | | | | | | | | C01=<div style="float: left; text-align: left">'''Mild to moderate'''
----
❑ Ambulatory patients <br>
❑ Tolerating oral diet <br>
❑ No dehydration <br>
❑ No toxicity <br>
❑ No abdominal tenderness or mass <br>
❑ No obstruction <br>
❑ [[Weight loss]] <10 percent <br>
</div>
| C02= <div style="float: left; text-align: left">'''Moderate to severe'''
----
❑ [[Fever]] <br>
❑ Intermittent nausea or vomiting <br>
❑ Mild to moderate dehydration <br>
❑ [[Anemia]] <br>
❑ Abdominal pain and tenderness <br>
❑ No obstruction <br>
❑ Weight loss > 10 percent <br>
</div>
| C03=<div style="float: left; text-align: left">'''Severe to fulminant'''
----
❑ High fever <br>
❑ Persistent vomiting <br>
❑ Severe [[dehydration]] <br>
❑ Significant [[peritoneal signs]] <br>
❑ Evidence of [[abscess]] <br>
❑ [[Intestinal obstruction]] <br>
❑ [[Cachexia]] <br>
</div> }}
{{familytree | | | | | | | |!| | | | | | | | | | | | | | | | | |!| | | | | | | | | | |!| | | | | | | | | | | | |}}
{{familytree | | | | | | | D01 | | | | | | | | | | | | | | | | D02 | | | | | | | | | D03 | | | | | | | | | | | | D01 =<div style="float: left; text-align: left"> ❑ Outpatient therapy <br> ❑ Start altered diet <br> ❑ Start [[oral rehydration therapy]]</div> | D02 =<div style="float: left; text-align: left"> ❑ Inpatient therapy <br> ❑ Start [[oral rehydration therapy]] or [[intravenous fluids]] based upon hydration status </div> | D03=<div style="float: left; text-align: left"> ❑ Inpatient therapy <br>  ❑ NPO <br> ❑ Start[[intravenous fluids]] <br> ❑ Consider total parental nutrition</div>}}
{{familytree | | | |,|-|-|-|+|-|-|-|.| | | | | | | | | | |,|-|-|^|-|-|.| | | |,|-|-|-|^|-|-|.| | | | | | | | | | | |}}
{{familytree | | | E01 | | E02 | | E03 | | | | | | | | | E04 | | | | E05 | | E06 | | | | | E07 | | E01=Oral lesion | E02= [[Ileitis]] and [[colitis]] | E03=Gastroduodenal disease |E04 = No steroid contraindication | E05= [[Steroid]] contraindicated | E06 = [[Abscess]] or [[peritonitis]] or [[intestinal obstruction|severe intestinal obstruction]] or refractory/severe painful fistulas | E07= No abscess or partial intestinal obstruction}}
{{familytree | | | |!| | | |!| | | |!| | | | | | | | | | |!| | | | | |!| | | |!| | | | | | |!| | | | | | | | | | | | | | |}}
{{familytree | | | F01 | | F02 | | F03 | | | | | | | | | F04 | | | | |!| | | |!| | | | | | F05 | | | | | F01=Topical [[triamcinolone acetonide]] | F02=<div style="float: left; text-align: left"> ❑ Illeitis and Rt side colitis: Oral [[budesonide]] (9 mg/day) <br>  ❑ Distal colitis : Topical mesalamine or topical steroids (enemas or suppositories) <br> ❑Other site : Oral [[mesalamine]] (4 g/day) or oral  [[sulfasalazine]] (3-6 g/day) </div>| F03=<div style="float: left; text-align: left"> ❑ [[proton pump inhibitor|PPI]] or [[H2 antagonist]], or [[sucralfate]]  <br>❑ Oral [[mesalamine]] (Pentasa: 2 g/day)</div>| F04 = Oral [[prednisone]] (40-60 mg/day) with or without mesalamine| F05 = Intravenous prednisone (40-60 mg/day)  }}
{{familytree | | | |`|-|-|-|+|-|-|-|'| | | | | | | | | | |!| | | | | |!| | | |!| | | | |,|-|^|-|-|-|.| | | | | | | | | | |}}
{{familytree | | | | | | | G01 | | | | | | | | | | | | | G02 | | | | |!| | | |!| | | | G03 | | | | G04 |G01= Response to treatment in 3-4 wks | G02 =Response to treatment | G03= No response to Rx| G04 = Significant response to Rx}}
{{familytree | | | |,|-|-|-|^|-|-|-|.| | | | | | | |,|-|-|^|-|.| | | |!| | | |!| | | | |!| | | | | |!| | | | | | |}}
{{familytree | | | H01 | | | | | | H02 | | | | | | H03 | | | H04 | | |!| | | |!| | | | H06 | | | | |!| | | | | | |H01=Yes | H02= No | H03=Yes | H04= No| H06= Intravenous[[cyclosporine]] or [[tacrolimus]]}}
{{familytree | | | |!| | | | | | | |!| | | | | | | |!| | | | |!| | | |!| | | |!| | |,|-|^|-|.| | | |!| | | | | | |}}
{{familytree | | | |!| | | | | | | I02 | | | | | | I03 | | | I01 | | |!| | | |!| | I04 | | I05 | | |!| | | | | | |I02= Oral [[metronidazole]] (10-20 mg/kg/day) | I03=<div style="float: left; text-align: left"> ❑Taper steroids by 5-10 mg/wk until 20 mg and then by 2.5-5 mg/wk until discontinuation of therapy <br> ❑ Baseline [[DEXA scan]]<br> ❑ Oral[[calcium]], [[vitamin D]] or [[bisphosphonates]] based on DEXA scan</div> | I01= Treat as '''severe to fulminant''' disease or consider the following | I04= No response to Rx |I05= Significant response to Rx}}
{{familytree | | | |!| | | | | |,|-|^|-|.| | | |,|-|^|-|.| | |!| | | |!| | | |!| | |!| | | |!| | | |!| | |}}
{{familytree | | | |!| | | | | J01 | | J02 | | J03 | | J04 | |!| | | |!| | | |!| | |!| | | |`|-|v|-|'| | |J01= Significant response | J02 = No response | J03= Steroid independent (No flare up of symptoms on tapering steroids)| J04=Steroid dependent (Flare up of symptoms on tapering steroids) }}
{{familytree | | | |`|-|-|v|-|-|'| | | |!| | | |!| | | |`|-|-|+|-|-|-|'| | | |!| | |!| | | | | X01 | | | | X01=Gradual transition to oral medications}}
{{familytree | | | | | | |!| | | | | | K02 | | |!| | | | | | K05 | | | | | | |!| | |!| | | | | | | | | | | | K02= Treat as '''moderate to severe disease''' | K05= <div style="float: left; text-align: left"> Consider '''methotrexate''' therapy
----
❑ A baseline [[CBC]], [[CXR]] and [[LFT]]<br>
❑ [[Methotrexate]] (25 mg/wk i.m and once improvement 15 mg/wk i.m or oral or s.c)
----
'''OR''' <br>
----
Consider '''anti-TNF monoclonal antibody''' therapy
----
❑ A baseline [[PPD]] and [[CXR]] (Rule out [[TB]]) <br>
❑  [[Infliximab]] (5 mg/kg i.v at 0, 2 and 6 wks)  <br>
'''OR''' <br>
❑ [[Adalimumab]] (160 mg s.c at 0 wk and 80 mg/2 wks)  <br>
'''OR''' <br>
❑ [[Certolizumab pegol]] (400 mg/4wk s.c)<br>
'''OR''' <br>
----
Consider '''Azthioprine or 6 MP''' therapy
----
❑ A baseline [[CBC]] and [[LFT]]<br>
❑ [[Azathioprine]] (2-3 mg/kg/day)<br>
'''OR''' <br>
❑ [[6-mercaptopurine]] (1-1.5 mg/kg/day)
</div> }}
{{familytree | | | | | | |!| | | | | | | | | | |!| | | |,|-|^|-|.| | | | | | |!| | |!| | | | | | | | | | | | | | | | | | |}}
{{familytree | | | | | | |!| | | | | | | | | | |!| | | L01 | | L02 | | | | | |!| | |!| | | | | | | | | | | L01= Significant response | L02= No response }}
{{familytree | | | | | | |!| | | | | | | | | | |!| | | |!| | | |`|-|-|-|v|-|-|^|-|-|'| | | | | | | | | | | | | | | | | | |}}
{{familytree | | | | | | M04 | | | | | | | | | M03 | | M01 | | | | | | M02 | | | | | | | | | | | | | | | | M04= <div style="float: left; text-align: left">'''Maintenance therapy'''
----
❑  [[Proctitis]]: Mesalamine suppositories <br>
'''OR''' <br>
❑ [[colitis|Distal colitis]] : Mesalamine enemas<br>
'''OR''' <br>
❑ Others: Oral [[sulfasalazine]] or [[olsalazine]] or [[mesalamine]](3-3.6 g/day) or [[balsalazide]] </div> |M03= <div style="float: left; text-align: left">'''Maintenance therapy'''
----
❑  [[Azathioprine]] (2-2.5 mg/kg) <br>
'''OR''' <br>
❑ [[6-mercaptopurine]] (1.5 mg/kg)
----
❑ Monitor [[CBC]] every 3 months ❑ Monitor periodically for side effects</div> | M01= <div style="float: left; text-align: left">'''Maintenance therapy'''
----
❑  [[Infliximab]] montherapy <br>
'''OR''' <br>
❑ Combined infliximab and [[azathioprine]] therapy<br>
'''OR''' <br>
❑ [[Methotrexate]] therapy (15 mg/wk i.m): For methotrexate induced remissions <br>
'''OR''' <br>
❑  [[Adalimumab]] therapy (40 mg/wk s.c): For adalimumab induced remissions <br>
'''OR''' <br>
❑ [[Certolizumab pegol]]  therapy (400 mg/ 4wk s.c): For certolizumab pegol  induced remissions <br>
'''OR''' <br>
❑ [[Natalizumab]] therapy (300 mg/ 4wk s.c): For natalizumab induced remissions <br>
----
❑ Monitor [[CBC]] every 3 months<br>❑ Monitor periodically for side effects</div> | M02= Surgical consultation (ileocolonic resections / abscess drainage / perioperative antibiotics)}}
{{familytree | | | | | | |!| | | | | | | | | | | | | | | | | | | | | | |!| | | | | | | | | | | | | | | | | | | | | | | | |}}
{{familytree | | | | | | N01 | | | | | | | | | | | | | | | | | | | | | N03 | | | | | | | | | | | | | | | | | | | | | | | | | N01= Azathioprine or 6-mercaptopurine for inadequate response | N03= <div style="float: left; text-align: left">'''Maintenance therapy'''
----
❑  [[Natalizumab]] therapy (300 mg/ 4wk s.c) <br>
'''OR''' <br>
❑ [[Infliximab]] montherapy (1.5 mg/kg)
----
❑ Monitor [[CBC]] every 3 months<br>❑ Monitor periodically for side effects </div>}}
{{familytree | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |}}
{{Family tree/end}}





Revision as of 16:31, 17 January 2014

Management

The algorithm is based on the American Journal of Gastroenterology guidelines for management of Crohn's disease in adults.[1]

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Characterize the symptoms:

Abdominal pain
Chronic diarrhea or nocturnal diarrhea

▸ Onset, duration, pattern, character (bloody, mucous, or watery)
Nausea
Vomiting
Abdominal distention
Fever
Loss of appetite
Loss of weight
Altered mental status
Hematochezia
Tenesmus


Extraintestinal symptoms:


Skin lesions
❑ Oral pain
Odynophagia and dysphagia
Joint pains
❑ Burning micturition
Cough, breathlessness
Eye pain, blurring of vision


Obtain detailed history:


❑ Recent travel H/O
❑ Recent drug H/O
❑ Abdominal/pelvic radiation H/O
❑ Family H/O

❑ Systemic illness H/O
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Assess volume status:

❑ General condition
❑ Thirst
Pulse
Blood pressure
❑ Eyes
❑ Mucosa


Examine the patient:


❑ Skin (swelling, pain, erythema or ulceration)
❑ Oral cavity (ulcers)
❑ Respiratory system (wheezing or crackles)
❑ Cardiovascular system
❑ Abdomen (mass, distension or tenderness)
❑ Anorectal (perianal skin tags, sinus tracts or bleeding)
❑ Eye (swelling, pain, edema or vision loss)
❑ Musculoskeletal (Axial, large and small joints)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Confirmatory diagnostic tests:
Colonoscopy and biopsy
❑ Upper GI scopy and biopsy
Computed tomography (CT)
Barium enema(length and location of strictures)
❑ Upper gastrointestinal series with small bowel follow through (SBFT)
Magnetic resonance imaging (enterography)
Wireless capsule endoscopy
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Findings suggestive of Crohn's disease:
❑ Discontinuous lesions
❑ Biopsy (Transmural inflammation, noncaseating granuloma)
❑ Cobblestoning (Serpiginous and linear ulcer)
❑ Normal rectum
❑ Isolated terminal ileum involvenent
❑ Aphthous ulcers
❑ Negative stool examination for infectious causes
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Assessment of severity
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Mild to moderate

❑ Ambulatory patients
❑ Tolerating oral diet
❑ No dehydration
❑ No toxicity
❑ No abdominal tenderness or mass
❑ No obstruction
Weight loss <10 percent

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Moderate to severe

Fever
❑ Intermittent nausea or vomiting
❑ Mild to moderate dehydration
Anemia
❑ Abdominal pain and tenderness
❑ No obstruction
❑ Weight loss > 10 percent

 
 
 
 
 
 
 
 
Severe to fulminant

❑ High fever
❑ Persistent vomiting
❑ Severe dehydration
❑ Significant peritoneal signs
❑ Evidence of abscess
Intestinal obstruction
Cachexia

 
 
 
 
 
 
 
 
 
 
 




References

  1. Lichtenstein, Gary R; Hanauer, Stephen B; Sandborn, William J (2009). "Management of Crohn's Disease in Adults". The American Journal of Gastroenterology. 104 (2): 465–483. doi:10.1038/ajg.2008.168. ISSN 0002-9270.